Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2010
05/25/2010US7723045 Assays to predict atherosclerosis and dysfunctional high-density lipoprotein
05/25/2010US7723044 Methods and apparatus for detection of viral infection
05/25/2010US7723043 applying a body-fluid sample to a solid phase immunoassay device comprising an anti-GPC3 antibody, quantifying the level of Glypican-3 (GPC3) protein in the sample
05/25/2010US7723042 Using parathyroid receptor epitope binding activity as a diagnostic indicator concentration of parathyroid hormone; diagnosing hyper/hypo-parathyroidism
05/25/2010US7723040 Detection of HIV-1 by nucleic acid amplification
05/25/2010US7723035 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells
05/25/2010US7723029 Biochips including ion transport detecting structures and methods of use
05/25/2010US7723025 detecting in the nucleic acids the presence of an A allele of a bovine stearoyl-CoA desaturase (SCD) gene to determine which bovine animal has high grade of meat, a higher percentage of monounsaturated fatty acid
05/25/2010US7723021 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases
05/25/2010US7723020 Use of azetidinone compounds
05/25/2010US7723019 Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof
05/25/2010US7723018 Identifying compounds which inhibit cell cycle progression for use in treating cell proliferative disorders agents for treat; antiproliferative/antitumor agents
05/25/2010US7722879 amino acid sequence proteins or immunogenic fragments, encoded sequence from isolated nucleic acid; for treating infection caused from Babesiidae; diagnostic test for the detection of nucleic acids, antibodies or antigens of the organism; safe, stable, easily scaleable production; veterinary medicine
05/25/2010US7722875 Antibodies that bind canine pancreatic lipase
05/25/2010US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells
05/25/2010US7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof
05/25/2010US7722858 Prevention and treatment of atherosclerosis by reducing carbamylation of LDL or the effects of carbamylated LDL
05/25/2010US7722809 Valveinterconnecting the first and second chambers dissolves and becomes a solute in the fluid in response to the bioagent presense in the fluid in the second chamber, where the valve is a membrane comprising peptide sequences to serve as recoginition elements for the bioagent; microfluidics
05/25/2010US7721961 Method of maintaining product item status using coded interface
05/25/2010US7721412 Method of making an electrochemical sensor
05/25/2010CA2559913C Microfluidic chip
05/25/2010CA2469393C Processes for the measurement of the potency of glatiramer acetate
05/25/2010CA2468275C Assaying apparatus, kit, and method for lipids and associated enzymes
05/25/2010CA2462922C Reverse-turn mimetics and method relating thereto
05/25/2010CA2424450C Method and device for identifying a marking
05/25/2010CA2420770C Highly reproducible agglutination immunoassay method and reagents
05/25/2010CA2404099C Method and apparatus for automatic pin detection in microarray spotting instruments
05/25/2010CA2390540C Apparatus and method for using fiducial marks on a microarray substrate
05/25/2010CA2377824C Gas monitoring system and environmentally controlled housing therefor
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2376132C Method and apparatus for detecting mastitis by using visible light and/or near infrared light
05/25/2010CA2324262C Confocal microscopy imaging system
05/25/2010CA2301077C Multi-layer testing column
05/25/2010CA2248243C Purification of tissue plasminogen activator (tpa)
05/25/2010CA2238613C Consensus phytases
05/25/2010CA2173130E Glutathione s-transferase-activated compounds
05/24/2010CA2686108A1 Method and system for non-destructive inspection of a colony of stress corrosion cracks
05/20/2010WO2010057184A2 Methods for detection of acute kidney injury in humans
05/20/2010WO2010057175A1 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
05/20/2010WO2010057135A2 Methods and compositions for predicting a subject's susceptibility to and risk of developing type 2 diabetes
05/20/2010WO2010057083A1 Methods of treating cancer
05/20/2010WO2010057078A2 Method and system for generating spatially and temporally controllable concentration gradients
05/20/2010WO2010057072A1 Method of analyzing a composition containing impurities
05/20/2010WO2010057020A2 Modification of amyloid-beta load in non-brain tissue
05/20/2010WO2010057014A2 Capturing and delivering molecules in a mammal
05/20/2010WO2010057005A2 Apparatus and method for detecting glycol
05/20/2010WO2010056966A2 Novel hiv-2 isolate
05/20/2010WO2010056945A2 Methods and systems for tissue processing and imaging
05/20/2010WO2010056898A2 Rapid expression cloning of human monoclonal antibodies from memory b cells
05/20/2010WO2010056893A1 Humanization and affinity-optimization of antibodies
05/20/2010WO2010056889A2 Use of an antibody and a rare-earth based crystal
05/20/2010WO2010056878A2 Electrochemical sensor module
05/20/2010WO2010056869A2 Electrochemical sensor module
05/20/2010WO2010056858A2 Bioluminescence imaging-based screening assay and inhibitors of abcg2
05/20/2010WO2010056815A1 Simultaneous measurment of the in vivo metabolism of isoforms of a biomolecule
05/20/2010WO2010056757A1 Biomarkers for assessing atherosclerotic potential
05/20/2010WO2010056753A1 Anti-cxcr1 compositions and methods
05/20/2010WO2010056744A2 Fluorescent neutralization and adherence inhibition assays
05/20/2010WO2010056740A1 Method of correction of particle interference to hemoglobin measurement
05/20/2010WO2010056734A2 Method for evaluating immunosuppression
05/20/2010WO2010056733A1 Combined use of bendamustine, doxorubicin and bortezomib for the treatment of multiple myeloma
05/20/2010WO2010056682A2 Methods for prediction of inflammatory bowel disease (ibd) using serologic markers
05/20/2010WO2010056681A2 Thyroid analyte detection and measurement
05/20/2010WO2010056525A2 Dissolution testing with in-situ gravimetric volume measurement
05/20/2010WO2010056509A2 Collection tubes apparatus, systems, and methods
05/20/2010WO2010056374A2 Methods and compositions of molecular profiling for disease diagnostics
05/20/2010WO2010056337A2 Methods and systems of using exosomes for determining phenotypes
05/20/2010WO2010056332A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010WO2010056300A2 Oximeter device
05/20/2010WO2010056185A1 Disposable cassette and method of use for blood analysis on blood analyzer
05/20/2010WO2010056123A1 Methods for identifying modulating compounds of lymphangiogenesis, means therefore, compounds and uses thereof
05/20/2010WO2010056026A2 Supports and gene arrays for in situ generation of protein arrays, protein arrays obtained therefrom, and methods for manufacture and use thereof
05/20/2010WO2010055959A1 System for detecting biomolecule wi th high sensitivity using micro-cant i lever
05/20/2010WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide
05/20/2010WO2010055916A1 Method for quantitatively determining cholesterol in low-density lipoproteins, reagent for quantitative determination, and quantitative determination kit
05/20/2010WO2010055883A1 Insoluble carrier for use in anti-phospholipid antibody measurement reagent, anti-phospholipid antibody measurement reagent, and method for measuring anti-phospholipid antibody
05/20/2010WO2010055867A1 Method for determining therapeutic effect of reperfusion therapy
05/20/2010WO2010055789A1 Oligonucleotide derivative, labeling agent, and use of the labeling agent
05/20/2010WO2010055584A1 Method of determining stress history and composite material obtained mainly from cement
05/20/2010WO2010055525A1 Method for predicting a patient's responsiveness to anti-folate therapy
05/20/2010WO2010055510A2 Diagnosis of multiple sclerosis
05/20/2010WO2010055464A1 Measurement device for body fluid analysis
05/20/2010WO2010055355A1 Pregnancy testing
05/20/2010WO2010055307A1 Methods of enhancing translocation of charged analytes through transmembrane protein pores
05/20/2010WO2010055306A1 Electrode, electrochemical sensor and apparatus, and methods for operating the same
05/20/2010WO2010055287A1 Biocompatible electrode
05/20/2010WO2010055284A1 Assay
05/20/2010WO2010055262A1 Device and method for sampling and recovering stacked particles
05/20/2010WO2010055208A1 Modified avidins binding to small ligands
05/20/2010WO2010055207A1 Chelating, chelating agents and conjugates deriver thereof
05/20/2010WO2010055064A1 Assessment of protein degradation by measurement of collagen fragments
05/20/2010WO2010055062A1 Assessment of protein degradation by measurement of isomerised neo-epitope containing fragments
05/20/2010WO2010055058A1 Assessment of subchondral bone remodelling by measuring cathepsin k fragments of collagen type ii
05/20/2010WO2010054986A1 Fabric whiteness measurement system
05/20/2010WO2010054810A1 Prognosis and risk assessment in patients suffering from heart failure by determining the level of adm and bnp
05/20/2010WO2010054789A1 Pacap as a marker for cancer
05/20/2010WO2010054445A1 Detection of tannerella forsythia infection
05/20/2010WO2010054437A1 Vaccine strains of brachyspira hyodysenteriae
05/20/2010WO2010037395A3 Mhc multimers in cancer vaccines and immune monitoring
05/20/2010WO2010037027A3 Immunization of avians by mucosal administration of non-replicating vectored vaccines
1 ... 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 ... 3937